Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3765070012 | Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
3765071011 | Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 3 | |
Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) | Has precise active ingredient | Sulfathiazole | true | Inferred relationship | Existential restriction modifier | 3 | |
Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) | Has basis of strength substance | Sulfathiazole | true | Inferred relationship | Existential restriction modifier | 3 | |
Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 3 | |
Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) | Count of base of active ingredient | 3 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) | Has manufactured dose form | Conventional release vaginal cream | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 3 | |
Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) | Has concentration strength numerator value | 34.2 | false | Inferred relationship | Existential restriction modifier | 3 | |
Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) | Is a | Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) | Has concentration strength numerator value | 37 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) | Has precise active ingredient | Sulfabenzamide | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) | Has basis of strength substance | Sulfacetamide sodium | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) | Has precise active ingredient | Sulfacetamide sodium | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) | Has basis of strength substance | Sulfabenzamide | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) | Has concentration strength numerator value | 28.6 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets